Ave Maria Growth Fund’s third-quarter 2025 investor letter showed a -0.48% return compared to the S&P 500 Index’s 8.12% return. Top holding AptarGroup, Inc. (NYSE:ATR) saw a one-month return of 2.89% and closed at $120.56 per share on January 6, 2026, with a market cap of $7.943 billion.

Ave Maria Growth Fund initiated a position in AptarGroup, Inc. (NYSE:ATR) in Q3 2025. The company, known for drug delivery solutions, faced near-term challenges, leading to share value decline. Despite this, Ave Maria sees long-term undervalued potential in AptarGroup, Inc. (NYSE:ATR).

29 hedge fund portfolios held AptarGroup, Inc. (NYSE:ATR) at the end of Q3 2025, with potential for investment but AI stocks offering greater upside. Check out reports on undervalued AI stocks and best 52-week low mid-cap stocks for more investment opportunities. Explore hedge fund investor letters for additional insights.

Read more at Yahoo Finance: Is AptarGroup (ATR) an Undervalued Stock?